Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.2 USD | +2.05% | -1.72% | +4.78% |
May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.